British infants to get meningitis vaccine

August 28, 2006

British health officials are beginning an immunization program designed to prevent infants and young children from contacting meningitis and septicemia.

A vaccine to prevent penumococcal disease will now be given to infants at 2, 4 and 13 months as part of regular immunizations, the London Telegraph reports.

In addition to killing 20 percent of its victims, pneumococcal disease can cause brain damage, deafness and epilepsy in those who survive.

Of the 530 cases recorded in England and Wales last year, 150 to 200 were infants under the age of two.

Symptoms of meningitis include stiff neck, extreme drowsiness and lack of appetite.

For infants a high-pitched cry and not wanting to be handled may also be evidence of the illness.

Copyright 2006 by United Press International

Explore further: Research finds new way to determine protection of Men B vaccine against different strains

Related Stories

Research finds new way to determine protection of Men B vaccine against different strains

June 18, 2018
Researchers at the University of Leicester and Meningococcal Reference Unit have developed a new approach to assess the effectiveness of the Men B vaccine, Bexsero, against different strains that cause meningococcal meningitis ...

Antibiotic prescriptions in infants may impact the effectiveness of important vaccinations

May 10, 2018
Findings from a South Australian-led study on antibiotic use and the effectiveness of vaccinations could have significant implications for vaccination programs globally.

Nigeria and health epidemics: acting quickly for a reason

May 10, 2018
A new outbreak of Ebola that has killed 17 people in the Democratic Republic of Congo is thousands of miles (kilometres) from Nigeria.

Study finds only half of infants with deadly meningitis show traditional signs of the disease

February 26, 2018
Researchers at St George's, University of London, say their new study shows the classic symptoms associated with bacterial meningitis are uncommon in young infants less than three months of age – the group at highest risk ...

Pneumococcal rates plunge after widespread vaccination of infants

May 27, 2013
The number of young children contracting the most common strains of potentially fatal pneumococcal disease has plummeted 97% since the universal vaccination against this bacterial disease began in 2005, with unvaccinated ...

WHO grants approval for safe, effective meningitis A vaccine for infants

January 9, 2015
The World Health Organization (WHO) has opened the door to routine immunization of infants in sub-Saharan Africa by approving for use an innovative and affordable vaccine that has all but rid the meningitis belt of a major ...

Recommended for you

New ALS therapy in clinical trials—drug extends survival, reverses some neuromuscular damage in animals

July 16, 2018
About 20,000 people in the United States are living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The invariably fatal disease kills the nerve cells that control walking, eating and breathing. ...

New platform poised to be next generation of genetic medicines

July 16, 2018
A City of Hope scientist has discovered a gene-editing technology that could efficiently and accurately correct the genetic defects that underlie certain diseases, positioning the new tool as the basis for the next generation ...

Magnetized wire could be used to detect cancer in people, scientists report

July 16, 2018
A magnetic wire used to snag scarce and hard-to-capture tumor cells could prove to be a swift and effective tactic for early cancer detection, according to a study by researchers at the Stanford University School of Medicine.

Yale-developed test for Alzheimer's disease directly measures synaptic loss

July 16, 2018
Yale researchers have tested a new method for directly measuring synaptic loss in individuals with Alzheimer's disease. The method, which uses PET imaging technology to scan for a specific protein in the brain linked to synapses, ...

Overcoming a major barrier to developing liquid biopsies

July 16, 2018
The idea of testing blood or urine to find markers that help diagnose or treat disease holds great promise. But as technology has improved to allow researchers to examine tiny fragments of RNA, one major problem has led to ...

Genetic marker for drug risk in multiple sclerosis offers path toward precision medicine

July 16, 2018
A team of researchers has uncovered a specific gene variant associated with an adverse drug reaction resulting in liver injury in a people with multiple sclerosis (MS). It is the first time researchers have been able to establish ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.